Literature DB >> 1533861

Toxicodynamics of tumour promoters of mouse skin. III. Specific binding of the tumour promoter thapsigargin as measured by the cold-acetone filter assay.

S B Christensen1, M Hergenhahn, H Roeser, E Hecker.   

Abstract

A method is described for measuring rapid, specific, and saturable binding of the skin irritant and tumour-promoting secretagogue thapsigargin (sesquiterpene lactone) to the microsomal fraction from mouse brain. Employing the tritium-labelled compound its apparent dissociation constant, Kd, and the maximal amount of binding Bmax are shown to be 9.8 nM and 1.9 pmol/mg protein respectively. Such a Kd for thapsigargin is similar to (a) its IC50 value for inhibiting Ca2+ uptake in the microsomal fraction from rat brain and (b) its EC50 values for inducing a rise in the cytoplasmic Ca2+ concentration of human platelets and histamine release from rat peritoneal mast cells. A positive correlation is found between the binding affinities of thapsigargin, thapsitranstagin, and trilobolide, their potencies as secretagogues and their lipophilicities. This correlation does not extend to the skin-irritant activities of the compounds thus emphasizing that their mechanism of action is unlike that of 12-O-tetradecanoylphorbol 13-acetate.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1533861     DOI: 10.1007/bf01294438

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  20 in total

1.  Cyclic AMP-dependent phosphorylation of a brain inositol trisphosphate receptor decreases its release of calcium.

Authors:  S Supattapone; S K Danoff; A Theibert; S K Joseph; J Steiner; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  [On the active substances in croton oil. 6. Inflammation tests on the mouse ear].

Authors:  E Hecker; H Immich; H Bresch; H U Schairer
Journal:  Z Krebsforsch       Date:  1966

3.  Specific binding of phorbol ester tumor promoters to mouse skin.

Authors:  K B Delclos; D S Nagle; P M Blumberg
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

4.  Inositol trisphosphate and thapsigargin discriminate endoplasmic reticulum stores of calcium in rat brain.

Authors:  A Verma; D J Hirsch; M R Hanley; O Thastrup; S B Christensen; S H Snyder
Journal:  Biochem Biophys Res Commun       Date:  1990-10-30       Impact factor: 3.575

5.  Stimulation of arachidonic acid metabolism in rat peritoneal macrophages by thapsigargin, a non-(12-O-tetradecanoylphorbol-13-acetate) (TPA)-type tumor promoter.

Authors:  K Ohuchi; T Sugawara; M Watanabe; N Hirasawa; S Tsurufuji; H Fujiki; T Sugimura; S B Christensen
Journal:  J Cancer Res Clin Oncol       Date:  1987       Impact factor: 4.553

Review 6.  Cell membrane associated protein kinase C as receptor of diterpene ester co-carcinogens of the tumor promoter type and the phenotypic expression of tumors.

Authors:  E Hecker
Journal:  Arzneimittelforschung       Date:  1985

7.  Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase.

Authors:  O Thastrup; P J Cullen; B K Drøbak; M R Hanley; A P Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

8.  The ability of thapsigargin and thapsigargicin to activate cells involved in the inflammatory response.

Authors:  H Ali; S B Christensen; J C Foreman; F L Pearce; W Piotrowski; O Thastrup
Journal:  Br J Pharmacol       Date:  1985-07       Impact factor: 8.739

9.  A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells.

Authors:  T R Jackson; S I Patterson; O Thastrup; M R Hanley
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

10.  Specific binding of the tumor promoter TPA in various mouse organs as measured by a "cold acetone-filter assay'.

Authors:  M Hergenhahn; E Hecker
Journal:  Carcinogenesis       Date:  1981       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.